How Time Shapes Living with Waldenstrom (WM)
In WM, time isn’t just a measurement — it’s a strategy. This year, the European Educational Forum will explore how time shapes every stage of living with Waldenstrom Macroglobulinemia (WM) — from diagnosis and monitoring to treatment decisions and future therapies....
Being Brain Healthy: A March Webinar
with Marilyn Abrahamson, MA, CCC-SL Thursday, March 26th at 2:30pm EDT Join Marilyn Abrahamson, MA, CCC-SLP, a brain health coach, to learn evidence-based strategies to help improve mental clarity, attention, and cognitive stamina. This interactive IWMF webinar is...
NORD Breakthrough Summit 2025
From VOICES to BREAKTHROUGHS NORD® Breakthrough Summit 2025 October 19–21 | Washington, DC With Cyndi Powers, CMP This past week, I had the privilege of attending the NORD® Breakthrough Summit in Washington, DC, for the third time. Hosted by the National Organization...
Welcome Delora Senft as the New President & CEO of IWMF
Welcome Delora Senft as the New President & CEO of IWMF We’re excited to share that Delora Senft will be joining International Waldenstrom’s Macroglobulinemia Foundation (IWMF) as our new President and CEO on August 18. A Proven Leader in Cancer Research and Advocacy...
Into the world—Welcome Bexobrutideg!
Accelerate the Cure Into the world—Welcome Bexobrutideg! We recently wrote about a new type of drug—a BTK degrader— that emerged in 2024, for phase one trials at Nurix Therapeutics and BeOne. The Nurix trial earned FDA fast-track status in December. In a short three...
Discover the 2024 IWMF Annual Report – Progress, Hope, and a Path to a Cure
If you have Waldenstrom’s macroglobulinemia (WM), care for someone who does, or simply believe in the power of research, you’ll want to read the 2024 IWMF Annual Report. This year’s report highlights how the International Waldenstrom’s Macroglobulinemia Foundation...
The Next Big Thing? Protein BTK Degraders
We are encouraged and excited to share ground-breaking news from Nurix Therapeutics, a pharmaceutical partner in WM-NET, our growing network of 22 US research institutions coordinating Waldenstrom’s macroglobulinemia (WM) clinical trials, supported by Accelerate...
Thank You! The 2025 WM Giving Challenge.
Thank You for Helping Us Accelerate the Cure! A big thank-you to everyone in the IWMF community who supported Accelerate the Cure during our Global Challenge Research Tour! We had 1,291 people visit a research lab during the Tour. About 25% of them used our French,...